FDA DrugClass IINotable
FDA Recall: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Single-dose 8 mL
Description
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Hazard
Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.
Remedy
21,930 Cartons
Related Recalls
2026-04-29 · FDA_DRUG
FDA Recall: Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton, NDC 0555-1054-56, with
Teva Pharmaceuticals USA, Inc
2026-04-15 · FDA_DRUG
FDA Recall: Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharm
Teva Pharmaceuticals USA, Inc
2026-04-15 · FDA_DRUG
FDA Recall: Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Cover
Teva Pharmaceuticals USA, Inc
2026-04-15 · FDA_DRUG
FDA Recall: Isotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharm
Teva Pharmaceuticals USA, Inc